Bruce Mackle | Investor Relations, LifeSci Advisors |
Steve Fruchtman | President & Chief Executive Officer |
Mark Gelder | Chief Medical Officer |
Mark Guerin | Chief Operating Officer & Chief Financial Officer |
Charles Zhu | Guggenheim |
Chun Lung | Ladenburg |
Robert LeBoyer | Noble Capital Markets |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Second Quarter 2022 Financial Results and Business Update Conference Call. At this time all participants are in listen only mode.
Following management's prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today, August 11, 2022.